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A B S T R A C T
Little is known about the long term prognosis of refractory epilepsy patients who do not undergo
epilepsy surgery. We performed a telephone survey and chart review of patients who underwent
presurgical evaluation in our Unit but did not have surgery, from 1998 until 2004. We contacted 84
patients; mean follow-up was 6.7 years. Four patients (4.7%) had died, presumably of SUDEP. Ten
patients (13.1%) were seizure free. In most patients with seizures, frequency remained stable (24/80,
30%) or had decreased by 50% (26 patients, 30.9%). Most patients (69, 86.2%) believed their health was
similar or better respect to the moment they underwent presurgical evaluation. Employment situation
was stable in 64/80 patients (80%), but 11 had received new disability wages. Family situation was also
generally unchanged (69/80 patients, 86.2%). Most patients were not taking antidepressants. Seizure free
patients scored higher in satisfaction with life. This information can be used to counsel refractory
patients.
 2011 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Refractory epilepsy is associated with cognitive and social
impairment, poor quality of life and increased risk of death.
However, natural history of established refractory epilepsy is not
well known. The objective of our study was to ﬁnd out the long
term prognosis (seizure and social outcome) of patients with
refractory epilepsy who were evaluated in our epilepsy unit but did
not undergo epilepsy surgery.
2. Methods
We performed a retrospective chart review and a telephone
survey of patients who underwent presurgical evaluation in our
Unit from 1998 until 2004 but did not have epilepsy surgery
afterwards. We excluded patients with a previous diagnosis of
drug resistant focal epilepsies who turned out to be generalized
epilepsies and generalized epilepsies with known bad prognosis
(for example patients with Lennox–Gastaut syndrome). From chart
review we assessed: age at seizure onset, type of epilepsy, etiology,
lesion on the MRI, seizure frequency when presurgical evaluation
was performed, and reason why surgery was not performed.* Corresponding author. Tel.: +34 932275414; fax: +34 932275783.
E-mail address: mcarreno@clinic.ub.es (M. Carren˜o).
1059-1311/$ – see front matter  2011 British Epilepsy Association. Published by Else
doi:10.1016/j.seizure.2011.04.010Once the patients were contacted by phone and permission was
given to participate in the study, we inquired about current seizure
frequency, AED use, overall impression of change (better, worse or
similar respect to the time they were evaluated), and current level
of satisfaction with life, rated by the patients on a 5-point global
categorical scale. We also asked about marital and employment
situation, neurological and psychiatric follow up.
Descriptive statistics for continuous variables, parametrical and
non parametrical tests were used.
3. Results
Of a total population of 110 patients, we were able to contact 84
patients or families by phone; the rest could not be found, likely
due to change of address or telephone. All patients we contacted
agreed to participate in the study. In 4 patients who had died,
families or caregivers agreed to provide information about
circumstances surrounding death.
Mean age was 40.2 years (20–74); mean age at seizure onset
was 12.05 years (1–57); median follow up since presurgical
evaluation was performed was 6.7 years (2–11.1 years). Most
patients had focal (temporal and extratemporal) epilepsy. Demo-
graphic and epilepsy features of the 26 patients who could not be
located did not differ from the 84 patients included in the study.
The data is summarized in Table 1.vier Ltd. All rights reserved.
Table 1
Sociodemographic and epilepsy features of the patients included in the study and patients who could not be contacted.
Patients who were contacted Patients who could not be contacted
Number of patients 84 26
Mean age (years) 40.2 (20–74) 38.5 (19–61)
Mean age at seizure onset (years) 12.05 (1–57) 16.2 (2–48)
Median follow up until study was performed (years) 6.7 (2–11.1) 7.8 (3–10)
Type of epilepsy
Focal temporal 31 (36.9%) 11 (42.3%)
Focal extratemporal 43 (51.2%) 14 (53.8%)
Generalized 10 (11.9%) 1 (3.8%)
MRI
Lesional 46 (54.8%) 14 (53.8%)
Non lesional 38 (45.2%) 12 (46.1%)
Reasons for not having surgery
Multifocal seizure onset 29 (34.9%) 9 (34.6%)
Non conclusive presurgical evaluation 36 (42.8%) 15 (57.7%)
Surgery not offered because of risk to eloquent cortex 10 (11.9%) 0 (0%)
Surgery offered but patient refused 8 (9.5%) 2 (7.7%)
Seizure freedom achieved soon after presurgical evaluation 1 (1.2%) 0 (0%)
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having epilepsy surgery were mainly multifocal seizure onset (29
patients, 34.9% patients) or non conclusive presurgical evaluation
(36 patients, 42.8%). Less often, surgery was not offered due to
signiﬁcant risk to eloquent cortex or the patient rejected surgical
treatment (Table 1).
Four out of 84 (4.7%) patients had died. All of them had been
found dead without clear explanation; exitus was attributed to
sudden death in epilepsy (SUDEP). Of those 4 patients, 3 had
extratemporal and 1 had temporal lobe epilepsy. The etiology was
cryptogenic in 3 and symptomatic in 1. Patients who died had
lower seizure frequency (median: 3 seizures a month) than
patients who were alive (median: 10 seizures a month) when
presurgical evaluation was performed. There were no differences
regarding age or age at seizure onset.
Median monthly frequency of seizures when patients were
admitted to the EMU was 8.5 (1–240). Median frequency when the
study was performed was 4 a month (0–180). Forty seven patients
(58.8%) were seen regularly by epileptologists, and 33 (41.3%) by
general neurologists. Ten patients (13.1%) had been seizure free
when they were contacted and had been seizure free for at least the
previous 6 months. Seizure freedom was temporarily related to the
use of new antiepileptic drugs in 2 patients (pregabalin in 1 patient
and topiramate in another). In the rest, seizure freedom was
related to the use of ‘‘classical’’ antiepileptic drugs (phenytoin in 1Table 2
Seizure and social outcome.
Seizure freedom Decrease by 50% 
Seizure outcome 10/80 (13.1%) 26/80 (32.5%) 
Better health respect to
presurgical evaluation
Similar health to the
moment they had
presurgical evaluation
Subjective impression
of change
40/80 (50%) 29/80 (36.3%) 
New job during follow up Worsened employment
situation (unemployment
or disability wages)
Employment changes 3/80 (3.7%) 16/80 (20%) 
Improved family situation
(marriage, new stable couple)
Worse family situation
(divorce)
Family changes 6/80 (7.5%) 5/80 (6.25%) patient and clobazam in 2 patients) or occurred without clear
temporal relationship to changes in medications (5 patients). Eight
of these patients had focal epilepsy (1 temporal, 7 extratemporal)
and 2 had generalized epilepsy.
The effect of the follow-up on the likelihood of achieving
seizure freedom was assessed by means of parametric and non-
parametric tests and no statistically signiﬁcant effect was detected
(t-test, p = 0.377; Mann–Whitney test, p = 0.4494). We also
assessed the effect on a logistic model using time as a continuous
variable (p = 0.375) as well as tertiles (signiﬁcation test p = 0.628;
trend test p = 0.414) and quartiles (signiﬁcation test p = 0.929;
trend test p = 0.547). The results of this analysis together with the
small differences (0.76 years in medians and 0.77 years in means)
suggest that there was no relevant effect between both groups due
to the follow-up time.
Seizure and social outcome is summarized in Table 2. Seventy
out of eighty alive patients (87.5%) still had seizures. Seizure
frequency had decreased by 50% in 26 patients (32.5%); of those,
13 patients (16.2%) had a 75% reduction. Seizure frequency
remained stable or had changed by less than 50% in 31 patients
(38.5%). Seizure frequency had increased by 50% in 6 patients
(7.5%) and had increased by 100% in 7 patients (8.7%). Subjectively,
40 (50%) patients felt their health was better than at the time they
had been admitted, 29 patients (36.3%) felt it was similar and 11
patients (13.8%) felt it was worse.Decrease by 75% Similar seizure
frequency or
changes less than 50%
Increase
by 50%
Increase
by 100%
13/80 (16.2%) 31/80 (38.5%) 6/80 (7.5%) 7/80 (8.7%)
Worse health respect to
presurgical evaluation
11/80 (13.8%)
Stable employment
situation
64/80 (80%)
Stable
69/80 (86.2%)
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a stable couple, 45 patients were single and 2 patients were
divorced. When we contacted them, 34 patients were married or
lived with a stable couple, 39 were single and 7 patients were
divorced. Family situation had ‘‘improved’’ in 6 patients who got
married and ‘‘worsened’’ in 5 patients who got divorced. Family
situation remained stable in most patients (69, 86.2%).
When they were admitted, 38 patients were employed, 19
patients were unemployed, 20 patients received disability wages
and 3 patients were housewives. When we called them, 26 patients
were employed, 19 patients were unemployed, the number of
patients receiving disability wages had increased (31 patients) and
4 patients were housewives. Only 3 patients got a new job during
the follow up, employment situation had worsened (disability or
unemployment) in 16 patients and remained stable in 64. Most
patients (65, 81.2%) were not taking antidepressant or antipsy-
chotic medications when the study was performed. Sixteen
patients had regular psychiatric follow up and 64 patients did not.
In a global categorical scale ranging from 1 (very low
satisfaction) to 5 (high satisfaction), 18 patients (22.5%) rated
their global satisfaction with life as 1 or 2, 29 patients (36.25%) as 3,
and 33 patients (41.25%) as 4 or 5. Higher scores seemed to be
associated with seizure freedom; median score in the seizure free
group was 5, being 3 in the group with persisting seizures (data not
shown).
4. Discussion
Patients with drug resistant epilepsy who turn out not to be
good surgical candidates often ask their epileptologists about long
term prognosis. Available information regarding long term
outcome and consequences of refractory epilepsy may be
discouraging.1,2 However, in a previous study including 34 patients
who were evaluated for epilepsy surgery and did not have surgery,
with a follow up of more than 4 years after presurgical evaluation,
up to 21% were found to be seizure free.3 Seizure freedom in our
series was slightly lower, 13.1%, similar to the percentage reported
in other studies which included patients with refractory epilepsy
prospectively followed in a tertiary center.4 Due to the nature of
the study, we could not assess the inﬂuence of the length of the
follow up in the likelihood of achieving remission using survival
curves and this is a serious limitation of our study, but using other
statistical tests we could not ﬁnd such an effect in our series.
Seizure remission seems to be ‘‘spontaneous’’ in some patients.
This has been previously described in other studies and may point
to a relapsing remitting course not always inﬂuenced by treatment.
However, and given the fact that in some patients remission is
temporarily related to an antiepileptic drug trial (either ‘‘classical’’
or ‘‘new’’), it is reasonable that most antiepileptic drugs are tried
rationally in drug resistant patients, always balancing seizure
control against possible side effects.5
Our study also shows that seizure frequency tends to remain
stable, and only a minority of patients experience a signiﬁcant
increase; most perceive their general health as similar or better
respect to the moment they were admitted in the Unit. As
intractability may follow long periods of seizure freedom, many
refractory patients are afraid of having more frequent and more
severe seizures in the future. This study shows that it is not usually
the case.We found out that 4 out of 84 patients had been found dead,
presumably of SUDEP. Of course, some of these patients may have
died of other medical conditions; however it conﬁrms the
increased mortality in this population and reinforces the need
for counselling in patients felt to be at risk.6
Refractory epilepsy is associated with psychosocial dysfunc-
tion. Our study was not designed to address all aspects of social
functioning; however it shows that during the follow up period,
family situation remained stable in most patients and work
situation worsened, with more patients receiving disability wages
over time (as expected in a chronic disease). It is known that even
after epilepsy surgery, employment gains are modest and seen
mainly in the seizure free patients.7
The fact that most patients were not taking antidepressant
drugs or had regular psychiatric follow does not necessarily imply
lack of depression in this population; it is known that this
condition remains undiagnosed in many patients. Unfortunately, a
telephone survey does not allow adequate assessment of mood,
cognitive changes or adverse effects of medications, all of them
known to have a signiﬁcant impact on quality of life, which could
not be properly assessed either.8,9 Using a rough system of a 5 point
categorical scale, satisfaction with life seemed to be higher in
seizure free patients, as previously reported.10,11
In summary, our study shows that seizure frequency in patients
with drug resistant epilepsy tends to remain stable or improve over
time; a minority of patients have signiﬁcant worsening or become
seizure free. This may happen spontaneously or in temporal
relationship with a new antiepileptic drug trial. Family situation
generally stays similar, and more patients will be on disability
wages over time. Most patients included in this study felt that their
health was similar or better respect to the moment they
undewerwent presurgical evaluation. This information may be
useful to counsel drug resistant patients who cannot undergo
epilepsy surgery.
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